Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the class of n-benzoylpiperidines. It is also known by the code name AR-C120011 and as ligand XXZ in structural biology databases. The molecule has been studied primarily as an experimental inhibitor of inducible nitric oxide synthase (iNOS or NOS2), with structural data available from murine iNOS-inhibitor complexes. There are no approved indications or clinical trials beyond preclinical/structural studies, and it is not approved for any therapeutic use[1][3][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 1-[4-(aminomethyl)benzoyl]-5'-fluoro-1'H-spiro[piperidine-4,2'-quinazolin]-4'-amine.